Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007.

Morrissey I, Maher K, Williams L, Shackcloth J, Felmingham D, Reynolds R; BSAC Working Parties on Resistance Surveillance.

J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii97-103. doi: 10.1093/jac/dkn356.

PMID:
18819984
2.

Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.

Farrell DJ, Felmingham D, Shackcloth J, Williams L, Maher K, Hope R, Livermore DM, George RC, Brick G, Martin S, Reynolds R; BSAC Working Parties on Resistance Surveillance.

J Antimicrob Chemother. 2008 Nov;62 Suppl 2:ii87-95. doi: 10.1093/jac/dkn355.

PMID:
18819983
3.

In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.

Loeffler A, Baines SJ, Toleman MS, Felmingham D, Milsom SK, Edwards EA, Lloyd DH.

J Antimicrob Chemother. 2008 Dec;62(6):1301-4. doi: 10.1093/jac/dkn398. Epub 2008 Sep 26.

PMID:
18819974
4.

Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004.

Felmingham D, Cantón R, Jenkins SG.

J Infect. 2007 Aug;55(2):111-8. Epub 2007 Jun 12. Review.

PMID:
17568680
5.

Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors.

Livermore DM, Reynolds R, Stephens P, Duckworth G, Felmingham D, Johnson AP, Murchan S, Murphy O, Gungabissoon U, Waight P, Pebody R, Shackcloth J, Warner M, Williams L, George RC.

Int J Antimicrob Agents. 2006 Oct;28(4):273-9. Epub 2006 Sep 14.

PMID:
16973337
6.

Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary.

Felmingham D.

J Chemother. 2005 Aug;17 Suppl 1:3-4. No abstract available.

PMID:
16429623
7.

Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003).

Schito GC, Felmingham D.

Int J Antimicrob Agents. 2005 Dec;26(6):479-85. Epub 2005 Nov 9.

PMID:
16289710
8.
9.

The Alexander Project: the benefits from a decade of surveillance.

Felmingham D, White AR, Jacobs MR, Appelbaum PC, Poupard J, Miller LA, Grüneberg RN.

J Antimicrob Chemother. 2005 Oct;56 Suppl 2:ii3-ii21.

PMID:
16282278
10.

Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae.

Farrell DJ, Morrissey I, Bakker S, Buckridge S, Felmingham D.

J Antimicrob Chemother. 2005 Oct;56(4):773-6. Epub 2005 Aug 11.

PMID:
16096320
11.

The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae.

Farrell DJ, Felmingham D.

J Antimicrob Chemother. 2005 Oct;56(4):795-7. Epub 2005 Aug 9. No abstract available.

PMID:
16091419
12.
13.

In vitro activity of telithromycin against Gram-negative bacterial pathogens.

Felmingham D, Farrell DJ.

J Infect. 2006 Mar;52(3):178-80. Epub 2005 Jul 5.

PMID:
15996744
14.

PROTEKT years 1-3 (1999-2002): study design and methodology.

Harding I, Felmingham D.

J Chemother. 2004 Dec;16 Suppl 6:9-18. No abstract available.

PMID:
15690682
15.

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Ball AP, Bartlett JG, Craig WA, Drusano GL, Felmingham D, Garau JA, Klugman KP, Low DE, Mandell LA, Rubinstein E, Tillotson GS.

J Chemother. 2004 Oct;16(5):419-36. Review.

PMID:
15565907
16.

Comparative antimicrobial susceptibility of respiratory tract pathogens.

Felmingham D.

Chemotherapy. 2004;50 Suppl 1:3-10. Review.

PMID:
15319548
18.

Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis.

Dohar J, Cantón R, Cohen R, Farrell DJ, Felmingham D.

Ann Clin Microbiol Antimicrob. 2004 Aug 2;3:15.

19.
20.

Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections.

Low DE, Felmingham D, Brown SD, Rangaraju M, Nusrat R.

J Infect. 2004 Aug;49(2):115-25.

PMID:
15236918
21.
22.

Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000.

Koeth LM, Felmingham D, Jacobs MR, Rossi F.

Int J Antimicrob Agents. 2004 Apr;23(4):356-61.

PMID:
15081084
23.

Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance.

Farrell DJ, Morrissey I, Bakker S, Morris L, Buckridge S, Felmingham D.

J Clin Microbiol. 2004 Feb;42(2):764-8.

24.

PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea.

Inoue M, Lee NY, Hong SW, Lee K, Felmingham D.

Int J Antimicrob Agents. 2004 Jan;23(1):44-51.

PMID:
14732313
26.

Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000).

Felmingham D, Farrell DJ, Reinert RR, Morrissey I.

J Infect. 2004 Jan;48(1):39-55.

PMID:
14667791
27.

Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.

Reynolds R, Shackcloth J, Felmingham D, MacGowan A; BSAC Extended Working Party on Respiratory Resistance Surveillance.

J Antimicrob Chemother. 2003 Dec;52(6):931-43. Epub 2003 Oct 29.

PMID:
14585865
28.

Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.

Reynolds R, Shackcloth J, Felmingham D, MacGowan A; BSAC Extended Working Party on Respiratory Resistance Surveillance.

J Antimicrob Chemother. 2003 Dec;52(6):925-30. Epub 2003 Oct 29.

PMID:
14585864
29.

The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN; Alexander Project Group.

J Antimicrob Chemother. 2003 Aug;52(2):229-46. Epub 2003 Jul 15.

PMID:
12865398
30.

Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000).

Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, Zoccoli CM, López H, Súcari A, Rossi F, Angulo GB, Segura AJ, Starling C, Mimica I, Felmingham D.

Braz J Infect Dis. 2003 Feb;7(1):44-61.

PMID:
12807691
31.

Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.

Farrell DJ, Douthwaite S, Morrissey I, Bakker S, Poehlsgaard J, Jakobsen L, Felmingham D.

Antimicrob Agents Chemother. 2003 Jun;47(6):1777-83.

32.
33.

Molecular characterization and antimicrobial susceptibility of fluoroquinolone-resistant or -susceptible Streptococcus pneumoniae from Hong Kong.

Morrissey I, Farrell DJ, Bakker S, Buckridge S, Felmingham D.

Antimicrob Agents Chemother. 2003 Apr;47(4):1433-5.

34.

A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.

Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D.

J Infect. 2003 Feb;46(2):94-100.

PMID:
12634070
35.

Surveillance of resistance in bacteria causing community-acquired respiratory tract infections.

Felmingham D, Feldman C, Hryniewicz W, Klugman K, Kohno S, Low DE, Mendes C, Rodloff AC.

Clin Microbiol Infect. 2002;8 Suppl 2:12-42. Review.

37.
39.

The need for antimicrobial resistance surveillance.

Felmingham D.

J Antimicrob Chemother. 2002 Sep;50 Suppl S1:1-7. Review.

PMID:
12239224
40.

Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.

Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Lin G, Felmingham D, Dencer C, Koeth L, Singer ME, Good CE.

J Clin Microbiol. 2002 Sep;40(9):3269-76.

42.
43.

Activity of the ketolide antibacterial telithromycin against typical community-acquired respiratory pathogens.

Felmingham D, Zhanel G, Hoban D.

J Antimicrob Chemother. 2001 Sep;48 Suppl T1:33-42. Review.

PMID:
11566974
44.

Microbiological profile of telithromycin, the first ketolide antimicrobial.

Felmingham D.

Clin Microbiol Infect. 2001;7 Suppl 3:2-10. Review.

45.

Instrumentation in antimicrobial susceptibility testing.

Felmingham D, Brown DF.

J Antimicrob Chemother. 2001 Jul;48 Suppl 1:81-5.

PMID:
11420341
46.

Penicillin resistance in pneumococci.

Felmingham D, Tesfaslasie Y, Burley C, Masterton RG.

J Antimicrob Chemother. 2000 May;45(5):710-1. No abstract available.

PMID:
10797100
49.

Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.

Butler DL, Gagnon RC, Miller LA, Poupard JA, Felmingham D, Grüneberg RN.

J Antimicrob Chemother. 1999 Jun;43(6):777-82.

PMID:
10404316
50.

Supplemental Content

Loading ...
Support Center